-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Sofosbuvir metabolite GS331007-[13C,d3]
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/1256490-42-2.gif)
| Category | Hepatitis C Virus (HCV) |
| CAS | 1256490-42-2 |
| Description | An isotope labelled metabolite of Sofosbuvir. Sofosbuviis a medication used for the treatment of hepatitis C. |
Product Information
| Molecular Weight | 264.23 |
| Molecular Formula | C9[13C]H10D3FN2O5 |
| Purity | 95% by HPLC; 98% atom D;98% atom 13C |
| Solubility | In Vitro: 10 mM in DMSO |
| Appearance | White to light yellow (Solid) |
| Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
| PSA | 104.55000 |
| Target | HCV |